%0 Journal Article
%T Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetes
%A Brooke S Carter
%A Jessica W Skelley
%A Megan Z Roberts
%J Archive of "Vascular Health and Risk Management".
%D 2018
%R 10.2147/VHRM.S168472
%K antihyperglycemic
%K sodium-glucose co-transporter 2 inhibitors
%K cardiovascular disease
%K diabetes mellitus
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292223/